Clinical Trial Update: Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating apixaban for stroke prophylaxis in patients with atrial fibrillation and advanced chronic kidney disease (CKD stage 5); curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiovascular Disease
• Chronic Kidney Disease
• End-stage Renal Disease
• Intracerebral Hemorrhage
• Stroke
• Venous Thromboembolism

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Region Stockholm | Conditions: Chronic Kidney Diseases, Atrial Fibrillation | Phase 3 | Status: RECRUITING